Related Experiment Video
Updated: Oct 3, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Circumstances of bronchiolitis obliterans development after lung transplantation: analysis of risk factors
A Pereszlenyi1, S Harustiak, W Klepetko
1Clinic of Thoracic Surgery, National Tubercolosis and Respiratory Diseases Institute, Bratislava. Arpad_pp@hotmail.com
Abstract:
Bronchiolitis obliterans after lung transplantation is the major factor which limits the long term survival. It affects 35-68% of those patients who survive longer than 3 months. Nowadays, the results of treatment and evaluation of bronchiolitis obliterans risk factors are not very encouraging. Although several risk factors of the development of bronchiolitis obliterans have already been identified, their role and importance have not been clearly defined yet. The objective of this article is to give an overview of the current international knowledge in treatment strategies and analyse to international trends in the research of risk factors of the development of this complication together with available results. Special attention is given to donor and recipient risk factors. (Tab. 2, Fig. 1, Ref. 32.)
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

